Search Within

Katja Schindler

Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (8)
  2. Dermatology (7)
  3. Dermatology Service (7)
  4. Division of Subspecialty Medicine (7)
  5. Survivorship Research (7)
  6. Solid Tumor Oncology Division (5)

More Groups

People
  1. Mario Lacouture (7)
  2. Kathryn Ciccolini (2)
  3. Klaus Busam (2)
  4. Mrinal Gounder (2)
  5. Viswanath Reddy Belum (2)
  6. Alexander Drilon (1)

More People

Years
  1. 2016 (1)
  2. 2015 (4)
  3. 2014 (3)
Publications
  1. Journal of Clinical Oncology (3)
  2. Journal of the American Academy of Dermatology (2)
  3. Breast Cancer Research and Treatment (1)
  4. Experimental Dermatology (1)
  5. Supportive Care in Cancer (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Mosby Elsevier (2)
  3. Springer (1)
  4. Springer Verlag (1)
  5. Wiley Blackwell (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Skin rashes induced by vemurafenib are caused by a non-allergic mechanism
    Meeting Abstract

    Friedrich, H. C.; Gerber, P. A.; Kislat, A.; Schindler, K.; Klossowski, N.; Braun, S. A.; Chapman, P.; Lacouture, M. E.; Homey, B.; Meller, S.
    Experimental Dermatology (2016)

    Fulltext@MSK | Save
  • Dermatologic toxicities of 3,517 solid tumor patients on phase I clinical trials of the National Institutes of Health Cancer Therapy Evaluation Program (CTEP)
    Meeting Abstract

    Drilon, A. E.; Eaton, A.; Schindler, K.; Gounder, M. M.; Smith, G. L.; Vulih, D.; Harris, P. J.; Spriggs, D. R.; Ivy, P.; Iasonos, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Reply to: "Skin moisturization for xerosis related to targeted anticancer therapies"
    Journal Article

    Valentine, J.; Belum, V. R.; Duran, J.; Ciccolini, K.; Schindler, K.; Wu, S.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2015)

    Fulltext@MSK | Save
  • A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies
    Journal Article

    Chan, A.; Cameron, M. C.; Garden, B.; Boers-Doets, C. B.; Schindler, K.; Epstein, J. B.; Choi, J.; Beamer, L.; Roeland, E.; Russi, E. G.; more...
    Supportive Care in Cancer (2015)

    Fulltext@MSK | Save
  • Incidence and risk of xerosis with targeted anticancer therapies
    Journal Article

    Valentine, J.; Belum, V. R.; Duran, J.; Ciccolini, K.; Schindler, K.; Wu, S.; Lacouture, M. E.
    Journal of the American Academy of Dermatology (2015)

    Fulltext@MSK | Save
  • Correlation of absolute and relative eosinophil counts with immune-related adverse events in melanoma patients treated with ipilimumab
    Meeting Abstract

    Schindler, K.; Harmankaya, K.; Kuk, D.; Mangana, J.; Michielin, O.; Hoeller, C.; Dummer, R.; Pehamberger, H.; Wolchok, J. D.; Postow, M. A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinical and histologic characterization of dermatologic adverse events front the pan-PI3K inhibitor buparlisib (BKM-120)
    Meeting Abstract

    Schindler, K.; Abraham, R.; Shah, P. D.; Chandarlapaty, S.; Paik, P. K.; Bell-Mcguinn, K.; Bajorin, D. F.; Mellinghoff, I. K.; Younes, A.; Gounder, M. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: A case series
    Journal Article

    Sibaud, V.; Niec, R. E.; Schindler, K.; Busam, K. J.; RocheĢ, H.; Modi, S.; Delord, J. P.; Lacouture, M. E.
    Breast Cancer Research and Treatment (2014)

    Fulltext@MSK | Save